TNF (tumor necrosis factor (TNF superfamily, member 2))
2004-06-01 Fei Chen   AffiliationHealth Effects Laboratory Division, NIOSH, 1095 Willowdale Rd, Morgantown, WV 26505, USA
Identity
HGNC
LOCATION
6p21.33
LOCUSID
ALIAS
DIF,TNF-alpha,TNFA,TNFSF2,TNLG1F
FUSION GENES
DNA/RNA
Description
The human TNFa gene has 4 exons spanning 2,762bp on the region of chromosome 6p21.3. The expression of TNFa gene generates a TNFa mRNA with size of 1,669nt. The 3-UTR region of TNFa mRNA contains a cluster of "AUUUA" elements that can be seen among many mRNAs with a short half-life, (AUUAUUUAUUAUUUAUUUAUUUAUUUAUUUAUUUA). A multiple NF-kB binding elements have been identified in the promoter region of TNFa gene.
Proteins

The phylogenetic tree of TNF superfamily members.
Description
The human TNFa protein contains 233 amino acids with a predicated molecular weight of 25.6 kDa. The TNFa is produced initially in a membrane-associated form, which is then subjected to enzymatic remove of the N-terminal 76 amino acids by TACE/ADAM17, a TNFa converting enzyme, to generate the soluble 17kDa TNFa molecule that forms homotrimer. TNFa is the first prototypic member identified in the TNF superfamily (TNFSF, Fig.1 and Table 1). The human TNF superfamily currently has 19 well-characterized members. Other members, such as TNFSF19, TNFSF21, and TNFSF22 have not been well-established. Although each member has its own receptor preference, a functional overlapping, such as induction of apoptosis and NF-kB activation, has been observed among the majority of these members. In addition, as indicated in the phylogenetic tree in Figure 1, all of these members exhibit an evolutional conservation in their amino acid sequences, many of which show characteristics of type II membrane proteins. These features of TNF superfamily suggest that the members in this family may derived from the same ancestral gene. Several members contain a C-terminal conserved domain, named the TNF-homology domain that shares 20-30% of sequence identity. Except TNFSF1 (lymphotoxin a) and TNFSF3 (lymphotoxin b) that can form either homotrimer or heterotrimer, the active form of other members in this family is homotrimer.
Expression
TNFa is expressed virtually in every type of cells in response to inflammatory signals.
Localisation
membrane (type II membrane protein), extracellular soluble form, blood stream, and biological fluids.
Function
The most abundant cellular sources of TNFa are macrophage and monocyte. In response to inflammatory stimulation, macrophage or monocyte secretes TNFa that can induce apoptotic or necrotic cell death of certain tumor cell lines. In addition, TNFa is also capable of inducing cell proliferation and differentiation in many types of cells under certain circumstances. TNFa can be a pyrogen that causes fever by its direct action or by stimulation of interleukin 1 secretion. Sustained generation of TNFa in a variety of human diseases, especially cancer and severe infection, can cause cachexia-like syndrome. The increased expression of TNFa in adipose tissue was considered to be responsible for the development of obesity or diabetes due to the induction of insulin resistance by TNFa. All of above functional characteristics of TNFa are executed through specific members of the TNF receptor (TNFR) superfamily, mainly TNFR1, the primary receptor for soluble TNFa, and TNFR2, the predominant receptor for membrane-associated TNFa. These receptors trigger several intracellular signaling pathways, most importantly, the IkB kinase (IKK) and mitogen-activated protein kinase (MAPK) cascades, which govern gene expression through NF-kBNF-kB and AP-1 transcription factors, respectively.
Implicated in
Disease
Arthritis, asthma, cancer, cardiovascular disorders, diabetes, HIV infection and AIDS, inflammatory bowel disease, lung fibrosis, obesity, septic shock, etc..
Cytogenetics
Mutations or polymorphisms in the promoter or coding region of TNFa gene have been associated with asthma, celiac, septic shock susceptibility, silicosis, Psoriasis, GVHD, Leprosy, etc..
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 12949498 | 2003 | Signalling pathways of the TNF superfamily: a double-edged sword. | Aggarwal BB et al |
| 14561180 | 2002 | The role of TNF and its family members in inflammation and cancer: lessons from gene deletion. | Aggarwal BB et al |
| 12860530 | 2003 | A co-evolution perspective of the TNFSF and TNFRSF families in the immune system. | Collette Y et al |
| 14698276 | 2004 | Inflammation: the link between insulin resistance, obesity and diabetes. | Dandona P et al |
| 12787559 | 2003 | The signaling adaptors and pathways activated by TNF superfamily. | Dempsey PW et al |
| 14580328 | 2003 | Adding facets to TNF signaling. The JNK angle. | Liu ZG et al |
| 12951580 | 2003 | Anti-TNF-alpha therapies: the next generation. | Palladino MA et al |
| 12102468 | 2002 | Tuberculous spondylitis: epidemiologic and clinical study in non-HIV patients from northwest Spain. | Rodriguez-Gomez M et al |
| 12965278 | 2003 | Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. | Szlosarek PW et al |
| 14980217 | 2004 | Tumor necrosis factor: an apoptosis JuNKie? | Varfolomeev EE et al |
| 12787557 | 2003 | The TNF superfamily. | Ware CF et al |
Other Information
Locus ID:
NCBI: 7124
MIM: 191160
HGNC: 11892
Ensembl: ENSG00000232810
Variants:
dbSNP: 7124
ClinVar: 7124
TCGA: ENSG00000232810
COSMIC: TNF
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000232810 | ENST00000449264 | P01375 |
| ENSG00000232810 | ENST00000449264 | Q5STB3 |
Expression (GTEx)
Pathways
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA10004 | adalimumab | Chemical | ClinicalAnnotation | associated | PD | 12190096, 12847678, 16720636, 16909270, 17343250, 18050183, 18438841, 18713756, 19365401, 22129793, 22760475, 22960943, 23057546, 24192118, 26244882 | |
| PA164713366 | Tumor necrosis factor alpha (TNF-alpha) inhibitors | Chemical | ClinicalAnnotation | associated | PD | 12190096, 12847678, 15695296, 16720636, 16909270, 17343250, 17673491, 18050183, 18438841, 18713756, 19365401, 22129793, 22760475, 22960943, 23057546, 24192118, 25311255, 26244882 | |
| PA164784021 | ethambutol | Chemical | ClinicalAnnotation | associated | PD | 22151084 | |
| PA164925725 | Toxic liver disease | Disease | ClinicalAnnotation | associated | PD | 22151084 | |
| PA165108401 | Acute coronary syndrome | Disease | ClinicalAnnotation | associated | PD | 18997459 | |
| PA165817016 | Kidney Transplantation | Disease | ClinicalAnnotation | associated | PD | 18444945 | |
| PA166114377 | hand-foot syndrome | Disease | ClinicalAnnotation | associated | PD | 22736425 | |
| PA443434 | Arthritis, Rheumatoid | Disease | ClinicalAnnotation | associated | PD | 12190096, 12847678, 15695296, 16720636, 16909270, 17343250, 17673491, 18050183, 18438841, 18713756, 19365401, 22129793, 22760475, 22960943, 23057546, 24192118, 25311255, 26244882 | |
| PA443622 | Carcinoma, Non-Small-Cell Lung | Disease | ClinicalAnnotation | associated | PD | 31616045 | |
| PA443815 | Crohn Disease | Disease | ClinicalAnnotation | associated | PD | 12190096, 12847678, 15695296, 16720636, 16909270, 17343250, 17673491, 18050183, 18438841, 18713756, 19365401, 22129793, 22760475, 22960943, 23057546, 24192118, 25311255, 26244882 | |
| PA444447 | Carcinoma, Hepatocellular | Disease | ClinicalAnnotation | associated | PD | 22736425 | |
| PA444546 | Hypersensitivity | Disease | ClinicalAnnotation | associated | PD | 11294926 | |
| PA444620 | Inflammation | Disease | ClinicalAnnotation | associated | PD | 12190096, 12847678, 16720636, 16909270, 17343250, 18050183, 18438841, 18713756, 19365401, 22129793, 22760475, 22960943, 23057546, 24192118, 26244882 | |
| PA445451 | Psoriasis | Disease | ClinicalAnnotation | associated | PD | 12190096, 12847678, 15695296, 16720636, 16909270, 17343250, 17673491, 18050183, 18438841, 18713756, 19365401, 22129793, 22760475, 22960943, 23057546, 24192118, 25311255, 26244882 | |
| PA445724 | Spondylitis, Ankylosing | Disease | ClinicalAnnotation | associated | PD | 12190096, 12847678, 15695296, 16720636, 16909270, 17343250, 17673491, 18050183, 18438841, 18713756, 19365401, 22129793, 22760475, 22960943, 23057546, 24192118, 25311255, 26244882 | |
| PA445846 | Thrombocytopenia | Disease | ClinicalAnnotation | associated | PD | 31616045 | |
| PA445941 | Tuberculosis | Disease | ClinicalAnnotation | associated | PD | 22151084 | |
| PA446198 | Arthritis, Psoriatic | Disease | ClinicalAnnotation | associated | PD | 12190096, 12847678, 16720636, 16909270, 17343250, 18050183, 18438841, 18713756, 19365401, 22129793, 22760475, 22960943, 23057546, 24192118, 26244882 | |
| PA447230 | HIV | Disease | ClinicalAnnotation | associated | PD | 20887379 | |
| PA448500 | atorvastatin | Chemical | ClinicalAnnotation | associated | PD | 18997459 | |
| PA448785 | carbamazepine | Chemical | ClinicalAnnotation | associated | PD | 11294926 | |
| PA448803 | carboplatin | Chemical | ClinicalAnnotation | associated | PD | 31616045 | |
| PA449167 | cyclosporine | Chemical | ClinicalAnnotation | associated | PD | 18444945 | |
| PA449515 | etanercept | Chemical | ClinicalAnnotation | associated | PD | 12190096, 12847678, 16720636, 16909270, 17343250, 18050183, 18438841, 18713756, 19365401, 22129793, 22760475, 22960943, 23057546, 24192118, 26244882 | |
| PA449748 | gemcitabine | Chemical | ClinicalAnnotation | associated | PD | 31616045 | |
| PA450112 | isoniazid | Chemical | ClinicalAnnotation | associated | PD | 22151084 | |
| PA450566 | mycophenolate mofetil | Chemical | ClinicalAnnotation | associated | PD | 18444945 | |
| PA451182 | pyrazinamide | Chemical | ClinicalAnnotation | associated | PD | 22151084 | |
| PA451250 | rifampin | Chemical | ClinicalAnnotation | associated | PD | 22151084 | |
| PA451494 | stavudine | Chemical | ClinicalAnnotation | associated | PD | 20887379 | |
| PA452639 | infliximab | Chemical | ClinicalAnnotation | associated | PD | 12190096, 12847678, 15695296, 16720636, 16909270, 17343250, 17673491, 18050183, 18438841, 18713756, 19365401, 22129793, 22760475, 22960943, 23057546, 24192118, 25311255, 26244882 | |
| PA7000 | sorafenib | Chemical | ClinicalAnnotation | associated | PD | 22736425 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37380786 | 2024 | The role of the cytokine TNF-α in choroidal neovascularization: a systematic review. | 1 |
| 37534543 | 2024 | Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor α in autoimmune hemolytic anemia and participate in Th17 polarization. | 2 |
| 37556005 | 2024 | Examining the link between TNF inhibition and alopecia areata using Mendelian randomization. | 0 |
| 37772688 | 2024 | Aptabinding of tumor necrosis factor-α (TNFα) inhibits its proinflammatory effects and alleviates islet inflammation. | 0 |
| 37842994 | 2024 | IL-6, IL-10 and TNF-α gene polymorphisms in preeclampsia: a case-control study in a Mexican population. | 0 |
| 37853768 | 2024 | Association of IL-6 rs1800795, but not TNF-α rs1800629, and IL-1β rs16944 polymorphisms' genotypes with recovery of ischemic stroke patients following thrombolysis. | 0 |
| 37991642 | 2024 | The 24-h profile of the DNA repair enzyme 8-oxoguanine glycosylase 1 (OGG1) is associated with age, TNF-α, and waist circumference in healthy adults. | 0 |
| 38008352 | 2024 | Low peripheral blood chemokine (C-C motif) ligand 5 and tumor necrosis factor α gene expression is associated with unfavorable progression of respiratory syncytial virus bronchiolitis in infants. | 0 |
| 38041410 | 2024 | Association of the TNF-α-308G>A gene polymorphism with left ventricular geometry and functional abnormalities in obstructive sleep apnea subjects. | 0 |
| 38051374 | 2024 | Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study. | 1 |
| 38084427 | 2024 | Molecular mechanisms underlying TNFα-induced mitochondrial fragmentation in human airway smooth muscle cells. | 1 |
| 38104742 | 2024 | TNF-α induced NF-κB mediated LYRM7 expression modulates the tumor growth and metastatic ability in breast cancer. | 1 |
| 38142424 | 2024 | Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis. | 0 |
| 38149816 | 2024 | Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma. | 1 |
| 38150890 | 2024 | Rs1800629 polymorphism in TNF-alpha is associated with the susceptibility and initial short-term glucocorticoids efficacy in myasthenia gravis patients. | 0 |
Citation
Fei Chen
TNF (tumor necrosis factor (TNF superfamily, member 2))
Atlas Genet Cytogenet Oncol Haematol. 2004-06-01
Online version: http://atlasgeneticsoncology.org/gene/319/tnf-(tumor-necrosis-factor-(tnf-superfamily-member-2))
